Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Although deep anesthesia can produce skeleton muscle relaxation,unnecessary deep anesthesia often had adverse cardiac effects and was related to 2-year mortality in cancer patients.The use of muscle relaxants allowed the depth of anesthesia to be optimized.However, for many anesthesiologists,in fear of residual postoperative neuromuscular blockade,intraoprative administration of muscle relaxants had to be minimized in spite of poor surgical conditions.
This study, however, is designed to test the hypothesis that profound neuromusclular blockade reduces muscle trauma caused by self-retaining retractor and thus cut down postoperative analgesic requirement.On the other hand,profound muscle relaxation can decrease postoperative diaphragmatic dysfunction and abdominal muscle trauma, which can improve postoperative pulmonary function.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| conventional neuromuscular blockade | No Intervention | No rocuronium will be administered intraoperatively unless there is surgeons' complain or patients movement | |
| optimal neuromuscular blockade | Active Comparator | Rocuronium dose will be infused to maintain depth of NMB at TOF count 1 intraoperatively |
|
| profound neuromuscular blockade | Experimental | Rocuronium dose will be infused to maintain a depth of NMB to PTC 1~2 intraoperatively |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| profound neuromuscular blockade | Drug | Rocuronium dose will be infused to maintain a depth of NMB to PTC 1~2 intraoperatively |
|
| Measure | Description | Time Frame |
|---|---|---|
| degree of muscle trauma | serum CK | 72h postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| postoperative analgesic requirement | consumption of morphine | 7days postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| postoperaive pulmonary function | FEV1 FVC PEF | 3days postoperatively |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ying Xiao, MD,PhD | Contact | 13570521662 | xying2603@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Ying Xiao, MD, PhD | First Affiliated Hospital, Sun Yat-Sen University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The First Affiliated Hospital of Sun Yat-sen University | Recruiting | Guangzhou | Guangdong | 510080 | China |
Not provided
Not provided
Not provided
Not provided
Not provided